These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 31748429

  • 1. Association between circulating zinc-α2-glycoprotein levels and the different phenotypes of polycystic ovary syndrome.
    Tang C, Li X, Tang S, Wang Y, Tan X.
    Endocr J; 2020 Mar 28; 67(3):249-255. PubMed ID: 31748429
    [Abstract] [Full Text] [Related]

  • 2. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome.
    Zhang L, Fang X, Li L, Liu R, Zhang C, Liu H, Tan M, Yang G.
    J Endocrinol Invest; 2018 Dec 28; 41(12):1401-1407. PubMed ID: 29785700
    [Abstract] [Full Text] [Related]

  • 3. Circulating Zinc-α2-glycoprotein levels and Insulin Resistance in Polycystic Ovary Syndrome.
    Lai Y, Chen J, Li L, Yin J, He J, Yang M, Jia Y, Liu D, Liu H, Liao Y, Yang G.
    Sci Rep; 2016 May 16; 6():25934. PubMed ID: 27180914
    [Abstract] [Full Text] [Related]

  • 4. Divergences in insulin resistance between the different phenotypes of the polycystic ovary syndrome.
    Moghetti P, Tosi F, Bonin C, Di Sarra D, Fiers T, Kaufman JM, Giagulli VA, Signori C, Zambotti F, Dall'Alda M, Spiazzi G, Zanolin ME, Bonora E.
    J Clin Endocrinol Metab; 2013 Apr 16; 98(4):E628-37. PubMed ID: 23476073
    [Abstract] [Full Text] [Related]

  • 5. Circulating zinc-α2-glycoprotein is reduced in women with polycystic ovary syndrome, but can be increased by exenatide or metformin treatment.
    Zheng S, Liu E, Zhang Y, Long T, Liu X, Gong Y, Mai T, Shen H, Chen H, Lin R, Zheng Y, Xie Y, Wang F.
    Endocr J; 2019 Jun 28; 66(6):555-562. PubMed ID: 30918134
    [Abstract] [Full Text] [Related]

  • 6. The natural logarithm of zinc-α2-glycoprotein/HOMA-IR is a better predictor of insulin sensitivity than the product of triglycerides and glucose and the other lipid ratios.
    Qu C, Zhou X, Yang G, Li L, Liu H, Liang Z.
    Cytokine; 2016 Mar 28; 79():96-102. PubMed ID: 26797477
    [Abstract] [Full Text] [Related]

  • 7. Increased chemerin serum levels in hyperandrogenic and normoandrogenic women from Argentina with polycystic ovary syndrome.
    Abruzzese GA, Gamez J, Belli SH, Levalle OA, Mormandi E, Otero P, Graffigna MN, Cerrone GE, Motta AB.
    Gynecol Endocrinol; 2020 Dec 28; 36(12):1057-1061. PubMed ID: 32496833
    [Abstract] [Full Text] [Related]

  • 8. Free androgen index and Irisin in polycystic ovary syndrome.
    Li H, Xu X, Wang X, Liao X, Li L, Yang G, Gao L.
    J Endocrinol Invest; 2016 May 28; 39(5):549-56. PubMed ID: 26584566
    [Abstract] [Full Text] [Related]

  • 9. Several Circulating Biomarkers for PCOS Diagnosis.
    Luo P, Zhang C, He Y, Yang G, Liu H, Li L.
    Exp Clin Endocrinol Diabetes; 2021 Oct 28; 129(10):705-712. PubMed ID: 31683329
    [Abstract] [Full Text] [Related]

  • 10. A case-control observational study of insulin resistance and metabolic syndrome among the four phenotypes of polycystic ovary syndrome based on Rotterdam criteria.
    Jamil AS, Alalaf SK, Al-Tawil NG, Al-Shawaf T.
    Reprod Health; 2015 Jan 16; 12():7. PubMed ID: 25595199
    [Abstract] [Full Text] [Related]

  • 11. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K, Katsikis I, Papadakis E, Kandaraki EA, Macut D, Panidis D.
    Hum Reprod; 2013 Mar 16; 28(3):785-93. PubMed ID: 23315058
    [Abstract] [Full Text] [Related]

  • 12. Zinc-α2-glycoprotein is associated with insulin resistance in humans and is regulated by hyperglycemia, hyperinsulinemia, or liraglutide administration: cross-sectional and interventional studies in normal subjects, insulin-resistant subjects, and subjects with newly diagnosed diabetes.
    Yang M, Liu R, Li S, Luo Y, Zhang Y, Zhang L, Liu D, Wang Y, Xiong Z, Boden G, Chen S, Li L, Yang G.
    Diabetes Care; 2013 May 16; 36(5):1074-82. PubMed ID: 23275352
    [Abstract] [Full Text] [Related]

  • 13. Hormone profiling, including anti-Müllerian hormone (AMH), for the diagnosis of polycystic ovary syndrome (PCOS) and characterization of PCOS phenotypes.
    Sova H, Unkila-Kallio L, Tiitinen A, Hippeläinen M, Perheentupa A, Tinkanen H, Puukka K, Bloigu R, Piltonen T, Tapanainen JS, Morin-Papunen L.
    Gynecol Endocrinol; 2019 Jul 16; 35(7):595-600. PubMed ID: 30668196
    [Abstract] [Full Text] [Related]

  • 14. Cross-sectional analysis of the effects of age on the hormonal, metabolic, and ultrasonographic features and the prevalence of the different phenotypes of polycystic ovary syndrome.
    Panidis D, Tziomalos K, Macut D, Delkos D, Betsas G, Misichronis G, Katsikis I.
    Fertil Steril; 2012 Feb 16; 97(2):494-500. PubMed ID: 22192350
    [Abstract] [Full Text] [Related]

  • 15. Effect of exposure to second-hand smoke from husbands on biochemical hyperandrogenism, metabolic syndrome and conception rates in women with polycystic ovary syndrome undergoing ovulation induction.
    Li J, Wu Q, Wu XK, Zhou ZM, Fu P, Chen XH, Yan Y, Wang X, Yang ZW, Li WL, Stener-Victorin E, Legro RS, Ng EH, Zhang H, Mol BWJ, Wang CC, for PCOSAct Study Group.
    Hum Reprod; 2018 Apr 01; 33(4):617-625. PubMed ID: 29471520
    [Abstract] [Full Text] [Related]

  • 16. Metabolic characteristics of different phenotypes in reproductive-aged women with polycystic ovary syndrome.
    Wen X, Wang L, Bai E.
    Front Endocrinol (Lausanne); 2024 Apr 01; 15():1370578. PubMed ID: 39109080
    [Abstract] [Full Text] [Related]

  • 17. Metabolic aspects of different phenotypes of polycystic ovary syndrome: Iranian PCOS Prevalence Study.
    Hosseinpanah F, Barzin M, Keihani S, Ramezani Tehrani F, Azizi F.
    Clin Endocrinol (Oxf); 2014 Jul 01; 81(1):93-9. PubMed ID: 24428207
    [Abstract] [Full Text] [Related]

  • 18. Insulin resistance and endocrine characteristics of the different phenotypes of polycystic ovary syndrome: a prospective study.
    Panidis D, Tziomalos K, Misichronis G, Papadakis E, Betsas G, Katsikis I, Macut D.
    Hum Reprod; 2012 Feb 01; 27(2):541-9. PubMed ID: 22144419
    [Abstract] [Full Text] [Related]

  • 19. The value of the free androgen index depends on the phenotype of polycystic ovary syndrome - a single-centre experience.
    Ożga K, Krzyczkowska-Sendrakowska M, Hubalewska-Dydejczyk A, Gilis-Januszewska A, Ratajczak M, Ratajczak M, Chaykivska Z, Jach R.
    Endokrynol Pol; 2019 Feb 01; 70(4):330-335. PubMed ID: 30938834
    [Abstract] [Full Text] [Related]

  • 20. Insulin resistance in a large cohort of women with polycystic ovary syndrome: a comparison between euglycaemic-hyperinsulinaemic clamp and surrogate indexes.
    Tosi F, Bonora E, Moghetti P.
    Hum Reprod; 2017 Dec 01; 32(12):2515-2521. PubMed ID: 29040529
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.